- Silk Road Medical Reports First Quarter 2024 Financial Results
- Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference
- Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024
- Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS
- Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System
- Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook
- Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
- Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Silk Road Medical Reports Third Quarter 2023 Financial Results
- Silk Road Medical Names Chas McKhann Chief Executive Officer
More ▼
Key statistics
As of last trade Silk Road Medical Inc (2OW:FRA) traded at 19.70, -35.62% below its 52-week high of 30.60, set on Jun 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.70 |
---|---|
High | 19.70 |
Low | 19.70 |
Bid | 19.70 |
Offer | 20.20 |
Previous close | 20.40 |
Average volume | 0.00 |
---|---|
Shares outstanding | 39.44m |
Free float | 37.76m |
P/E (TTM) | -- |
Market cap | 849.23m USD |
EPS (TTM) | -1.37 USD |
Data delayed at least 15 minutes, as of May 24 2024 07:10 BST.
More ▼